HomeMission | Investigators | Transgenic Mouse Facility | PCR Core Facility | Human Tumor BankCareer Opps
Funding Opportunities | Cancer Cell Biology Track | SCCCB Pre-doctoral Fellowship | Seminars | News | Related Links | Site Index


 
 


E. Brad Thompson, M.D.
 
Professor, Biochemistry & Molecular Biology
 Mary and J. Palmer Saunders Professor

email: 
bthompso@utmb.edu


 


Research interests:
 

This laboratory has a longstanding interest in the cellular and molecular actions of steroids, especially glucocorticoids and oxysterols. The lab has a record of leadership in this field and is actively pursuing several aspects of this work. Glucocorticoid actions on leukemic cells: Glucocorticoids cause many types of malignant lymphoid cells to die by the process known as apoptosis. Using a human leukemic cell line, we have discovered that the mechanism of this process involves rapid regulation of c-myc, c-jun, ODC and other genes important for cell cycling. Gene array analyses are being used in combination with somatic cell genetics to identify these. Interactions of the PKA, PKC and glucocorticoid pathways are being explored.  Structural studies of the glucocorticoid receptor: The functional structure of the major transcription-activating domain of the receptor is under study, using recombinant peptides and proteins. This domain seems to lack tertiary structure in its native state, but structure can be induced by use of osmolytes. This allows study of function. Methods: mutagenesis, protein expression and purification, CD, fluorescence emissions, ultracentrifugation, NMR, etc.  Use of glucocorticoid receptor gene fragment to cause cell death in the absence of steroid:  We have discovered that certain very small fragments of a mutated form of the glucocorticoid receptor are capable of causing cell death when transfected into several kinds of cancer cells. The mechanism of this effect may involve interaction with cellular transcription machinery.  These molecular steps are being worked out, and the application of this finding for a potentially novel form of therapy is being pursued through studies on efficient delivery mechanisms.



Kumar R, Thompson EB. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Molecular Endocrinology 17:1-10, 2003.

Medh RD, Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T Luxon BA, Thompson EB. Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics 81:543-55, 2003.

Kumar R, Thompson EB. DNA binding of nuclear hormone receptors influences their structure and function. Biochemical and Biophysical Research Communications 306:1-4, 2003.

Webb MS, Miller AL, Johnson BH, Fofanov Y, Li T, Wood TG, Thompson EB. Gene networks in glucocorticoid-evoked apoptosis in leukemic cells. Journal of Steroid Biochemistry and Molecular Biology 85:183-93, 2003.


HomeMission | Investigators | Transgenic Mouse Facility | PCR Core Facility | Human Tumor BankCareer Opps
Funding Opportunities | Cancer Cell Biology Track | SCCCB Pre-doctoral Fellowship | Seminars | News | Related Links | Site Index

This site published by Donna Davis for the Sealy Center for Cancer Cell Biology.
Copyright ©  2002  The University of Texas Medical Branch. Please review our privacy policy and Internet guidelines.

  Last Revised:  January 18, 2008